CVR - Coronavirus Vaccines R&D Roadmap

Milestone
3.5.b

Practical manufacturing systems

In progress

Support the development of broadly protective coronavirus vaccines that can be made with more practical and affordable manufacturing systems, to expand manufacturing to more regions, leading to more equitable distribution.

Progress Highlights

Dutt 2024: As of April 2023, the WHO mRNA Technology Transfer Hub, based in South Africa, had established partner companies in 15 LMICs.

Thompson 2023: Eight global COVID-19 vaccine developers have licenses or technology transfer agreements with countries in Africa.